Journals / Mikrobiyoloji Bülteni / 2008 / Cilt: 42 - Sayı: 4

A meningitis case of Brucella and tuberculosis co-infection

Menenjitli bir olguda Brucella ve tüberküloz koenfeksiyonu

Pages
689–694
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Since this was a rare case of Brucella and tuberculosis co-infection, this report emphasizes that such co-infections should be kept in mind especially in the endemic areas for tuberculosis and brucellosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Turkey is located at an endemic area for brusellosis and tuberculosis which are both important public health problems.
📊
Key Findings & Data:A 19-years-old woman was admitted to our clinic with severe headache, fever, vomiting, meningeal irritation symptoms, confusion and diplopia.
💡
Conclusion & Impact:Since this was a rare case of Brucella and tuberculosis co-infection, this report emphasizes that such co-infections should be kept in mind especially in the endemic areas for tuberculosis and brucellosis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Mycobacterium tuberculosis · Genç erişkin · Antitüberküler ajanlar

Abstract

Turkey is located at an endemic area for brusellosis and tuberculosis which are both important public health problems. Meningitis caused by Brucella and Mycobacterium spp. may be confused since the clinical and laboratory findings are similar. In this report, a meningitis case with Brucella and tuberculosis co-infection has been presented. A 19-years-old woman was admitted to our clinic with severe headache, fever, vomiting, meningeal irritation symptoms, confusion and diplopia. The patient was initially diagnosed as Brucella meningitis based on her history (stockbreeding, consuming raw milk products, clinical symptoms concordant to brucellosis lasting for 4-5 months), physical examination and laboratory findings of cerebrospinal fluid (CSF). Standard tube agglutination test for brucellosis was positive at 1/80 titer in CSF and at 1/640 titer in serum, whereas no growth of Brucella spp. was detected in CSF and blood cultures. Antibiotic therapy with ceftriaxone, rifampicin and doxycyclin was started, however, there was no clinical improvement and agitation and confusion of the patient continued by the end of second day of treatment. Repeated CSF examination yielded acid-fast bacteria. The patient was then diagnosed as meningitis with double etiology and the therapy was changed to ceftriaxone, streptomycin, morphozinamide, rifampicin and isoniazid for thirty days. Tuberculosis meningitis was confirmed with the growth of Mycobacterium tuberculosis on the 14th day of cultivation (BACTEC, Becton Dickinson, USA) of the CSF sample. On the 30th day of treatment she was discharged on anti-tuberculous treatment with isoniazid and rifampicin for 12 months. The follow-up of the patient on the first and third months of treatment revealed clinical and laboratory improvement. Since this was a rare case of Brucella and tuberculosis co-infection, this report emphasizes that such co-infections should be kept in mind especially in the endemic areas for tuberculosis and brucellosis.

Özet

Ülkemiz, önemli halk sağlığı sorunları olan gerek bruselloz gerekse tüberküloz için endemik bölgeler içinde yer almaktadır. Her iki etken tarafından oluşturulan menenjit tablosu ise, klinik ve laboratuvar bulguları açısından birbirine benzemekte ve karıştırılabilmektedir. Bu raporda, menenjit tanısı konulan bir hastada tespit edilen Brucella ve tüberküloz koenfeksiyonu sunulmaktadır. Hayvancılıkla uğraşan 19 yaşında bir kadın hasta, şiddetli baş ağrısı, kusma, ateş, şuur bulanıklığı, meningeal irritasyon bulguları ve diplopi yakınmalarıyla kliniğimize başvurmuştur. Başlangıçta hastaya, anamnez (hayvancılıkla uğraşma, çiğ süt ürünleri tüketimi, 4-5 aydır brusellozla uyumlu klinik bulguların varlığı), fizik muayene bulguları ve beyin omurilik sıvısı (BOS) laboratuvar bulguları ile Brucella menenjiti tanısı konulmuştur. BOS ve kan kültürlerinde Brucella spp. üremesi olmayan hastanın BOS'unda 1/80, serumunda 1/640 titrede standart tüp aglütinasyon (STA) testi ile Brucella antikor pozitifliği mevcuttur. Seftriakson, rifampisin ve doksisiklin tedavisi başlanan hastada, ikinci günün sonunda klinik düzelmenin olmaması ve ajitasyon ve şuur bulanıklığının devam etmesi üzerine tekrar alınan BOS örneğinin incelemesinde asidorezistan bakteri pozitifliği saptanmıştır. Bu bulgulara göre hastaya Brucella ve tüberküloz koenfeksiyonu ön tanısı konularak, tedavi seftriakson, streptomisin, rifampisin, izoniazid ve morfozinamid şeklinde değiştirilmiştir. Tüberküloz menenjiti tanısı, alınan BOS kültüründe (BACTEC, Becton Dickinson, ABD) 14. günde Mycobacterium tuberculosis üremesi üzerine doğrulanmıştır.Tedavinin birinci ve üçüncü aylarında yapılan kontrollerde, klinik ve BOS bulgularının düzeldiği gözlenmiş, herhangi bir şikayeti kalmayan hasta izleme alınmıştır. Olgumuz, Brucella ve tüberküloz menenjitinin bir arada görülmesi nedeniyle nadir saptanan bir olgu olup, bu enfeksiyonların endemik olduğu bölgelerde bu tür koenfeksiyonların görülebileceğinin akılda tutulması amacıyla sunulmuştur.

🔖

Cite This Article

KARSEN, H., KARAHOCAGİL, M. K., IRMAK, H., DEMİRÖZ, A. P. (2008). A meningitis case of Brucella and tuberculosis co-infection. Mikrobiyoloji Bülteni, Cilt: 42 - Sayı: 4, 689–694. https://ajindex.com/articles/298940

References (2)

  1. Akdeniz H, Irmak H, Anlar Ö, Demiröz AP. Central nervous system brucellosis: presentation, diagnosis and treatment, j Infect 1998; 36: 297-301. 2.Young EJ. Brucella species, pp: 2386-91. In: Mandell GL, Bennett JE, Dolin R (eds), Principles and Practice of Infectious Diseases. 2000, 5th ed. Churchill Livingstone, New York. 3.Haas DW. Mycobacterium tuberculosis, pp: 2576-604. In: Mandell GL, Bennett JE, Dolin R (eds), Principles and Practice of Infectious Diseases. 2000, 5th ed. Churchill Livingstone, New York. 4.oung EJ. Utility of the enzyme-linked immunosorbent assay for diagnosing neurobrucellosis. Clin Infect Dis 1998; 26: 1481. 5.Irmak H, Buzgan T, Evirgen Ö, et al. Use of the Brucella IgM and IgG flow assays in the serodiagnosis of human brucellosis in an area endemic for brucellosis. Am J Trop Med Hyg 2004; 70: 688-94. 6.Kaya S. Bruselloz ve tedavi sorunu. Infeksiyon Derg 2006; 20: 227-30. 7.Sanchez-Sousa A, Torres C, Campello MG, et al. Serological diagnosis of neurobrucellosis, j Clin Pathol 1990;43:79-81. 8.Bashir R, Zuheir Al-Kawi M, Harder ER, Jinkins j. Nervous system brucellosis: diagnosis and treatment. Neurology 1985; 35: 1576-81. 9.Baldi PC, Araj GF, Racaro GC, et al. Detection of antibodies to Brucella cytoplasmic proteins in the cerebrospinal fluids of patients with neurobrucellosis. Clin Diagn Lab Immunol 1999; 6: 756-9. 10.Kalkan A, Bulut V, Bulut S ve ark. Nörobruseliosis: olgu raporu. Infeksiyon Derg 2000; 14: 131-4. 11.Heper Y, Yılmaz E, Akalın H, Mistik R, Helvacı S. Nörobruselloz: 9 olgunun irdelemesi. Klimik Derg 2004; 17: 99-102. 12.Thomas R, Kameswaran M, Murugan V, Okator BC. Sensorineural hearing loss in neurobrucellosis. J Laryn-gol Otol 1993; 107: 1034-6. 13. Bahemuka M, Shemenna AR, Panayiotopoulus CP, Al-Aska AK, Abeid T, Daif AK. Neurological syndrome of brucellosis. J Neurol Neurosur Psychiatry 1998; 51: 1017-21. 14.Özdemir D, Albayrak F, Cesur S ve ark. Bir nörobruselloz olgusu. Infeksiyon Derg 2003; 17: 499-500. 15.Mutlu B, Bolca Z, Kalender B ve ark. Depresif semptomlarla seyreden ve tedavi intoleransı gözlenen bir nörobruselloz olgusu. Infeksiyon Derg 2002; 16: 99-101. 16.Pottuge JC, Harris AA. Chronic meningitis, p: 1415. In: Gorbach SL, Bartlett JG, Blacklow NR (eds), Infectious Diseases. 1998,
  2. WB Saunders Company, Philadelphia. 17. Gokce C, Kılıç SS, Mungan B, et al. Comparison of children and adults with tuberculous meningitis in Ela-zig, Turkey. ] Trop Pediatr 1992; 38: 116-8. 18.Hosoglu S, Geyik MF, Balık I,